Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population at Different Cardiac Sites

NCT06371170 is registered in ClinicalTrials.gov with Azienda Ospedaliero, Universitaria Ospedali Riuniti as lead sponsor.

NCT NCT06371170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population at Different Cardiac Sites
Lead sponsor
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
January 1, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracardiac thrombus